Related references
Note: Only part of the references are listed.The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics
Li Di
CURRENT DRUG METABOLISM (2019)
Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C-induced HIV latency reversal
Kouki Matsuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Getting the Kill into Shock and Kill: Strategies to Eliminate Latent HIV
Youry Kim et al.
CELL HOST & MICROBE (2018)
HIV Neuroinfection and Alzheimer's Disease: Similarities and Potential Links?
Geoffrey Canet et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro
Shin-ichiro Hattori et al.
FRONTIERS IN MICROBIOLOGY (2018)
Trends in the management levels of metabolic risk factors in middle-aged and elderly patients with type 2 diabetes mellitus: The Korean National Health and Nutrition Examination Survey 1998-2014
Sukyung Cho et al.
PLOS ONE (2017)
Synthesis and Evaluation of Dimeric Derivatives of Diacylglycerol-Lactones as Protein Kinase C Ligands
Nami Ohashi et al.
BIOCONJUGATE CHEMISTRY (2017)
Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity
Kouki Matsuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations
Gregory M. Laird et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation
Guochun Jiang et al.
PLOS PATHOGENS (2015)
Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy
Anthony R. Cillo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Histone Deacetylase Inhibitors Impair the Elimination of HIV-Infected Cells by Cytotoxic T-Lymphocytes
Richard Brad Jones et al.
PLOS PATHOGENS (2014)
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
Thomas A. Rasmussen et al.
LANCET HIV (2014)
BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism
Daniela Boehm et al.
CELL CYCLE (2013)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
N. M. Archin et al.
NATURE (2012)
Synthetic Caged DAG-lactones for Photochemically Controlled Activation of Protein Kinase C
Wataru Nomura et al.
CHEMBIOCHEM (2011)
Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner
Rajeev Mehla et al.
PLOS ONE (2010)
Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells
Xavier Contreras et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The Challenge of Finding a Cure for HIV Infection
Douglas D. Richman et al.
SCIENCE (2009)
Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs
Masakiyo Hosokawa
MOLECULES (2008)
Long-term HIV-1 infection of neural progenitor populations
Ina Rothenaigner et al.
AIDS (2007)
The use of a metallothionein-like-proteins (MTLP) kinetic approach for metal bioavailability monitoring in dredged material
M. Laura Martin-Diaz et al.
ENVIRONMENT INTERNATIONAL (2007)
Protein kinase C and other diacylglycerol effectors in cancer
Erin M. Griner et al.
NATURE REVIEWS CANCER (2007)
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Lydie Trautmann et al.
NATURE MEDICINE (2006)
Branched diacylglycerol-lactones as potent protein kinase C ligands and α-secretase activators
J Lee et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
PKD at the crossroads of DAG and PKC signaling
Qiming J. Wang
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice
CL Morton et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC
P Hampson et al.
BLOOD (2005)
Human immunodeficiency virus reactivation by phorbol esters or T-cell receptor Ligation requires both PKCα and PKCθ
SA Trushin et al.
JOURNAL OF VIROLOGY (2005)
The neuropathogenesis of AIDS
F Gonzalez-Scarano et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Can HIV be cured? Mechanisms of HIV persistence and strategies to combat it
DH Hamer
CURRENT HIV RESEARCH (2004)
CD38 expression in CD8+ T cells predicts virological failure in HIV type 1-infected children receiving antiretroviral therapy
S Resino et al.
CLINICAL INFECTIOUS DISEASES (2004)
Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice
R Etcheberrigaray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mechanical stress-activated PKCδ regulates smooth muscle cell migration
CH Li et al.
FASEB JOURNAL (2003)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
JD Siliciano et al.
NATURE MEDICINE (2003)
HIV reproducibly establishes a latent infection after acute infection of T cells in vitro
A Jordan et al.
EMBO JOURNAL (2003)
Conformationally constrained analogues of diacylglycerol (DAG).: 17.: Contrast between sn-1 and sn-2 DAG lactones in binding to protein kinase C
H Tamamura et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Conformationally constrained analogues of diacylglycerol (DAG). 16. How much structural complexity is necessary for recognition and high binding affinity to protein kinase C?
K Nacro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
